Elizabeth Trotta

Staff Reporter
Elizabeth Trotta joined TheStreet.com in 2007 after reporting on exchanges for Investment Dealers' Digest. Prior to that, she was a writer and associate editor with Advanstar Communications covering business management topics for Veterinary Economics and Firstline Magazine. She also held internships writing for Vance Publishing and PilgrimPage and was a graduate research assistant at KU. She has a B.A. in English and a B.S. and M.S. in journalism from the University of Kansas.
By This Author:
« Back
Page 1 of 60
Article

No Big Ripple for Merck Vioxx Verdict

By Elizabeth Trotta

A Texas appeals court reverses a $7.75 million verdict related to a 2006 case of a heart attack victim, but the drugmaker's planned settlements continue.

Related Topics: Health Care | Drugs

05:21PM 05/14/08

Article

Court Overturns Merck Vioxx Verdict

By Elizabeth Trotta

A Texas appeals court reverses a verdict related to a 2006 case of a heart attack victim.

Related Topics: Drugs | Health Care

04:30PM 05/14/08

Article

Health Winners & Losers: Merck

By Elizabeth Trotta

Genzyme climbs on a Wall Street upgrade.

Related Topics: Health Care | Winners & Losers

04:11PM 05/14/08

Article

Health Winners & Losers: Abbott

By Elizabeth Trotta

Abbott Labs climbs on new data from its Spirit III trial for its Xience V stent.

Related Topics: Winners & Losers | Health Care

03:58PM 05/13/08

Article

Iomai Surges on $189 Million Buyout

By Elizabeth Trotta

Foreign biotech Intercell will pay $6.60 a share for Iomi.

Related Topics: Biotech | Health Care | Drugs

10:15AM 05/13/08

Article

Health Winners & Losers: Isis

By Elizabeth Trotta

The biotech rises on a narrowed first-quarter loss.

Related Topics: Winners & Losers | Health Care

06:00PM 05/12/08

Article

Cell Genesys Issues Stock in Private Placement

By Elizabeth Trotta

A single institutional investor is paying $4.22 a share for 7.1 million shares.

Related Topics: Biotech | Health Care | Drugs

10:50AM 05/12/08

Article

Health Winners & Losers: Alnylam

By Elizabeth Trotta

Alnylam climbs on an earnigns beat.

Related Topics: Health Care | Winners & Losers

04:57PM 05/09/08

Article

Biotech Earnings Review: Celgene, Biogen

By Elizabeth Trotta

An overview of how seven big biotech companies fared in the January-March quarter.

Related Topics: Health Care | Drugs | Biotech

03:51PM 05/09/08

Article

Health Winners & Losers: Barr

By Elizabeth Trotta

Barr Pharma slides on an earnings miss.

Related Topics: Health Care | Winners & Losers

04:39PM 05/08/08

« Back
Page 1 of 60
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Premium Stock Ideas